Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis

被引:76
作者
Lobell, A
Weissert, R
Storch, MK
Svanholm, C
de Graaf, KL
Lassmann, H
Andersson, R
Olsson, T
Wigzell, H
机构
[1] Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden
[2] Karolinska Hosp, Ctr Mol Med, Neuroimmunol Unit, S-17176 Stockholm, Sweden
[3] Univ Vienna, Inst Neurol, A-1090 Vienna, Austria
关键词
D O I
10.1084/jem.187.9.1543
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We explore here if vaccination with DNA encoding an autoantigenic peptide can suppress autoimmune disease. For this purpose we used experimental autoimmune encephalomyelitis (EAE), which is an autoaggressive disease in the central nervous system and an animal model for multiple sclerosis. Lewis rats were vaccinated with DNA encoding an encephalitogenic T cell epitope, guinea pig myelin basic protein peptide 68-85 (MBP68-85), before induction of EAE with MBP68-85 in complete Freund's adjuvant. Compared to vaccination with a control DNA construct, the vaccination suppressed clinical and histopathological signs of EAE, and reduced the interferon gamma production after challenge with MBP68-85. Targeting of the gene product to Fc of IgG was essential for this effect. There were no signs of a Th2 cytokine bias. Our data suggest that DNA vaccines encoding autoantigenic peptides may be useful tools in controlling autoimmune disease.
引用
收藏
页码:1543 / 1548
页数:6
相关论文
共 25 条
[1]   A NOVEL TECHNIQUE TO LINK EITHER PROTEINS OR PEPTIDES TO GAMMA-GLOBULIN TO CONSTRUCT TOLEROGENS [J].
BOREL, H ;
BOREL, Y .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 126 (02) :159-168
[2]   SMALL B-CELLS AS ANTIGEN-PRESENTING CELLS IN THE INDUCTION OF TOLERANCE TO SOLUBLE-PROTEIN ANTIGENS [J].
EYNON, EE ;
PARKER, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :131-138
[3]   Late complications of immune deviation therapy in a nonhuman primate [J].
Genain, CP ;
Abel, K ;
Belmar, N ;
Villinger, F ;
Rosenberg, DP ;
Linington, C ;
Raine, CS ;
Hauser, SL .
SCIENCE, 1996, 274 (5295) :2054-2057
[4]   SPREADING OF THE IMMUNE-RESPONSE TO DIFFERENT MYELIN BASIC-PROTEIN PEPTIDES IN CHRONIC EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN B1O.RIII MICE [J].
JANSSON, L ;
DIENER, P ;
ENGSTROM, A ;
OLSSON, T ;
HOLMDAHL, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) :2195-2200
[5]   REVERSAL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY A SOLUBLE PEPTIDE VARIANT OF A MYELIN BASIC-PROTEIN EPITOPE - T-CELL RECEPTOR ANTAGONISM AND REDUCTION OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
KARIN, N ;
MITCHELL, DJ ;
BROCKE, S ;
LING, N ;
STEINMAN, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2227-2237
[6]   ORAL TOLERANCE TO MYELIN BASIC-PROTEIN AND NATURAL RECOVERY FROM EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS ARE ASSOCIATED WITH DOWN-REGULATION OF INFLAMMATORY CYTOKINES AND DIFFERENTIAL UP-REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND PROSTAGLANDIN-E EXPRESSION IN THE BRAIN [J].
KHOURY, SJ ;
HANCOCK, WW ;
WEINER, HL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1355-1364
[7]   Tandem repeats of T helper epitopes enhance immunogenicity of fusion proteins by promoting processing and presentation [J].
Kjerrulf, M ;
Lowenadler, B ;
Svanholm, C ;
Lycke, N .
MOLECULAR IMMUNOLOGY, 1997, 34 (8-9) :599-608
[8]   Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant [J].
Lorentzen, JC ;
Issazadeh, S ;
Storch, M ;
Mustafa, MI ;
Lassman, H ;
Linington, C ;
Klareskog, L ;
Olsson, T .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 63 (02) :193-205
[9]   IMMUNOLOGICAL ASPECTS OF DEMYELINATING DISEASES [J].
MARTIN, R ;
MCFARLAND, HF ;
MCFARLIN, DE .
ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 :153-187
[10]   Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide [J].
Marusic, S ;
Tonegawa, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :507-515